The humoral hypercalcemia of benignancy. A newly appreciated syndrome.
It has become recently appreciated that the hypercalcemia of malignancy is commonly caused by the increased production of parathyroid hormone-related protein (PTHrP) by the cancer. In fact, the demonstration of increased PTHrP production in a patient with hypercalcemia is regarded as pathognomonic of malignancy. The authors describe a patient with a benign ovarian lesion that produced PTHrP and caused hypercalcemia. They identify other reports of hypercalcemia associated with hypercalcemia and benign tumors, and refer to this syndrome as the humoral hypercalcemia of benignancy. Although apparently rare, a benign PTHrP-producing tumor should be considered in the differential diagnosis of hypercalcemia.
Knecht
T P
TP
Department of Medicine, University of California, San Diego School of Medicine, La Jolla, USA.
Behling
C A
CA
Burton
D W
DW
Glass
C K
CK
Deftos
L J
LJ
D000328:Adult; D002118:Calcium / Q000097:blood; D003884:Dermoid Cyst / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology*; D007150:Immunohistochemistry; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology; D010257:Paraneoplastic Syndromes / Q000209:etiology*; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D014176:Protein Biosynthesis
D009363:Neoplasm Proteins; C470121:PTHLH protein, human; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D002118:Calcium